Overview
Mitsushige Nakao practices practicing medicine in Otsu, Japan.
Their clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Multiple Myeloma.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mitsushige Nakao
Is Mitsushige Nakao a top-rated expert for B-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Mitsushige Nakao is classified as an Experienced expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mitsushige Nakao participate in research or clinical trials?
Yes. Mitsushige Nakao has published 16 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Mitsushige Nakao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaNakao isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Multiple MyelomaNakao isExperienced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaNakao isExperienced. Learn about Non-Hodgkin Lymphoma.